Company intelligence / Profile preview

Aluvis International

Wauwatosa / Milwaukee area, Wisconsin, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Commercial

Overview

Aluvis International has developed a UV-C light-based device designed to rapidly sanitize mobile handheld devices by significantly reducing microbial contamination and pathogens. The company’s technology is positioned as an intuitive, safe solution for infection control in healthcare and other high-contact environments. The product is commercially available.

Therapeutic areas: Infectious Diseases
Modalities: Device (UV-C light-based sanitization system)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Aluvis International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aluvis International.

Explore the full profile